Digital Health Accelerators Digital Health Today Ambassadors Digital Health Today Digital Health Today-Resources Digital Health Today Ambassadors

Biofourmis is not your typical standalone DTx company! On the heels of a $300M round, Biofourmis has evolved to a full data driven healthcare services organization with a strong foundation of digital therapies driving care decisions.

To learn more about their work and plans for the future, I went straight to Kuldeep Singh Rajput, founder and CEO of Biofourmis.

Biofourmis, in their own words, “utilizes machine learning, integrated technology and an FDA-cleared analytics engine to streamline connections between patients and care teams, leading to better outcomes for all.”

In this episode we cover:

  • The path from creation to funding
  • Digital therapeutic companies evolving into virtual care platforms
  • Kuldeep’s business hypothesis to entrepreneurial journey
  • Being device agnostic: build vs buy
  • Patient adoption and utilization
  • And much more!

Guest Links and Resources:

Host Links:

Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Presenting Partner

Contributing Sponsors

Industry Leaders Weigh in on the Recent Pear Therapeutics News and the Future of Prescription Digital Therapeutics In this special episode of DTx Podcast, Eugene is joined by Brent Vaughan, CEO of Cognito, as well as industry leaders from previous episodes, to weigh in on the recent Pear Therapeutics news and the future of prescription digital therapeutics.